EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.3.1.269 | additional information | generation of loss-of-function mutants of Lnt, i.e. lnt153::T26, phenotypes, overview | Acinetobacter baumannii |
2.3.1.269 | additional information | generation of loss-of-function mutants of Lnt, phenotypes, overview | Acinetobacter baylyi |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.269 | a phosphoglycerolipid + an [apolipoprotein]-S-1,2-diacyl-sn-glyceryl-L-cysteine | Acinetobacter baumannii | - |
a 1-lyso-phosphoglycerolipid + a [lipoprotein]-N-acyl-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
? | |
2.3.1.269 | a phosphoglycerolipid + an [apolipoprotein]-S-1,2-diacyl-sn-glyceryl-L-cysteine | Acinetobacter baylyi | - |
a 1-lyso-phosphoglycerolipid + a [lipoprotein]-N-acyl-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
? | |
2.3.1.269 | a phosphoglycerolipid + an [apolipoprotein]-S-1,2-diacyl-sn-glyceryl-L-cysteine | Acinetobacter baylyi BD413 | - |
a 1-lyso-phosphoglycerolipid + a [lipoprotein]-N-acyl-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
? | |
2.3.1.269 | a phosphoglycerolipid + an [apolipoprotein]-S-1,2-diacyl-sn-glyceryl-L-cysteine | Acinetobacter baylyi ATCC 33305 | - |
a 1-lyso-phosphoglycerolipid + a [lipoprotein]-N-acyl-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
? | |
2.3.1.269 | a phosphoglycerolipid + an [apolipoprotein]-S-1,2-diacyl-sn-glyceryl-L-cysteine | Acinetobacter baumannii AB5075-UW | - |
a 1-lyso-phosphoglycerolipid + a [lipoprotein]-N-acyl-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.269 | Acinetobacter baumannii | A0A090B6R9 | - |
- |
2.3.1.269 | Acinetobacter baumannii AB5075-UW | A0A090B6R9 | - |
- |
2.3.1.269 | Acinetobacter baylyi | Q6FF00 | - |
- |
2.3.1.269 | Acinetobacter baylyi ATCC 33305 | Q6FF00 | - |
- |
2.3.1.269 | Acinetobacter baylyi BD413 | Q6FF00 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.269 | a phosphoglycerolipid + an [apolipoprotein]-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
Acinetobacter baumannii | a 1-lyso-phosphoglycerolipid + a [lipoprotein]-N-acyl-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
? | |
2.3.1.269 | a phosphoglycerolipid + an [apolipoprotein]-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
Acinetobacter baylyi | a 1-lyso-phosphoglycerolipid + a [lipoprotein]-N-acyl-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
? | |
2.3.1.269 | a phosphoglycerolipid + an [apolipoprotein]-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
Acinetobacter baylyi BD413 | a 1-lyso-phosphoglycerolipid + a [lipoprotein]-N-acyl-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
? | |
2.3.1.269 | a phosphoglycerolipid + an [apolipoprotein]-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
Acinetobacter baylyi ATCC 33305 | a 1-lyso-phosphoglycerolipid + a [lipoprotein]-N-acyl-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
? | |
2.3.1.269 | a phosphoglycerolipid + an [apolipoprotein]-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
Acinetobacter baumannii AB5075-UW | a 1-lyso-phosphoglycerolipid + a [lipoprotein]-N-acyl-S-1,2-diacyl-sn-glyceryl-L-cysteine | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.269 | ALP N-acyltransferase | UniProt | Acinetobacter baumannii |
2.3.1.269 | lnt | - |
Acinetobacter baumannii |
2.3.1.269 | lnt | - |
Acinetobacter baylyi |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.3.1.269 | 37 | - |
assay at | Acinetobacter baumannii |
2.3.1.269 | 37 | - |
assay at | Acinetobacter baylyi |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.3.1.269 | 7.2 | - |
assay at | Acinetobacter baumannii |
2.3.1.269 | 7.2 | - |
assay at | Acinetobacter baylyi |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.3.1.269 | malfunction | Acinetobacter species can tolerate a complete loss-of-function mutation in gene lnt. Absence of a fully functional Lnt impairs modification of lipoproteins, increases outer membrane permeability and susceptibility to antibiotics, and alters normal cellular morphology. In addition, loss of lnt triggers a global transcriptional response to this added cellular stress. Without Lnt, the bacterial cell envelope becomes more permeable and modification of outer membrane lipoproteins is impaired. Cells of the lnt mutant have structural defects. The genome expression profile of Acinetobacter baylyi changes in response to lnt mutation. Phenotypes, overview | Acinetobacter baylyi |
2.3.1.269 | malfunction | Acinetobacter species can tolerate a complete loss-of-function mutation in gene lnt. Absence of a fully functional Lnt impairs modification of lipoproteins, increases outer membrane permeability and susceptibility to antibiotics, and alters normal cellular morphology. In addition, loss of lnt triggers a global transcriptional response to this added cellular stress. Without Lnt, the bacterial cell envelope becomes more permeable and modification of outer membrane lipoproteins is impaired. Phenotypes, overview | Acinetobacter baumannii |
2.3.1.269 | metabolism | genome expression profile of Acinetobacter baylyi changes in response to gene lnt mutation, overview | Acinetobacter baylyi |
2.3.1.269 | physiological function | proper acylation of outer membrane lipoprotein BamD requires enzyme Lnt in Acinetobacter baylyi. Lnt is required for full maturation of outer membrane lipoprotein BamD | Acinetobacter baylyi |